FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2551908528> ?p ?o ?g. }

• W2551908528 endingPage "523" @default.
• W2551908528 startingPage "523" @default.
• W2551908528 abstract "To investigate the potential of implanting pseudoislets formed from human insulin-releasing β-cell lines as an alternative to islet transplantation.In this study, the anti-diabetic potential of novel human insulin releasing 1.1B4 β-cells was evaluated by implanting the cells, either as free cell suspensions, or as three-dimensional pseudoislets, into the subscapular region of severe combined immune deficient mice rendered diabetic by single high-dose administration of streptozotocin. Metabolic parameters including food and fluid intake, bodyweight and blood glucose were monitored throughout the study. At the end of the study animals were given an intraperitoneal glucose tolerance test. Animals were then culled and blood and tissues were collected for analysis. Insulin and glucagon contents of plasma and tissues were measured by insulin radioimmunoassay and chemiluminescent enzyme-linked immunosorbance assay respectively. Histological analyses of pancreatic islets were carried out by quantitative fluorescence immunohistochemistry staining.Both pseudoislet and cell suspension implants yielded well vascularised β-cell masses of similar insulin content. This was associated with progressive amelioration of hyperphagia (P < 0.05), polydipsia (P < 0.05), body weight loss (P < 0.05), hypoinsulinaemia (P < 0.05), hyperglycaemia (P < 0.05 - P < 0.001) and glucose tolerance (P < 0.01). Islet morphology was also significantly improved in both groups of transplanted mice, with increased β-cell (P < 0.05 - P < 0.001) and decreased alpha cell (P < 0.05 - P < 0.001) areas. Whereas mice receiving 1.1B4 cell suspensions eventually exhibited hypoglycaemic complications, pseudoislet recipients displayed a more gradual amelioration of diabetes, and achieved stable blood glucose control similar to non-diabetic mice at the end of the study.Although further work is needed to address safety issues, these results provide proof of concept for possible therapeutic applicability of human β-cell line pseudoislets in diabetes." @default.
• W2551908528 created "2016-11-30" @default.
• W2551908528 creator A5001268925 @default.
• W2551908528 creator A5005742368 @default.
• W2551908528 creator A5010536397 @default.
• W2551908528 creator A5075620817 @default.
• W2551908528 date "2016-01-01" @default.
• W2551908528 modified "2023-09-26" @default.
• W2551908528 title "Implanting 1.1B4 human β-cell pseudoislets improves glycaemic control in diabetic severe combined immune deficient mice" @default.
• W2551908528 cites W1199087362 @default.
• W2551908528 cites W1911808314 @default.
• W2551908528 cites W195774709 @default.
• W2551908528 cites W1969259632 @default.
• W2551908528 cites W1971438560 @default.
• W2551908528 cites W1975799894 @default.
• W2551908528 cites W1984170856 @default.
• W2551908528 cites W1986466599 @default.
• W2551908528 cites W1988160514 @default.
• W2551908528 cites W1997688914 @default.
• W2551908528 cites W2004869365 @default.
• W2551908528 cites W2011104428 @default.
• W2551908528 cites W2011450045 @default.
• W2551908528 cites W2012387946 @default.
• W2551908528 cites W2018784771 @default.
• W2551908528 cites W2020017933 @default.
• W2551908528 cites W2028575457 @default.
• W2551908528 cites W2030802628 @default.
• W2551908528 cites W2055492712 @default.
• W2551908528 cites W2058601364 @default.
• W2551908528 cites W2059854083 @default.
• W2551908528 cites W2064250803 @default.
• W2551908528 cites W2064502515 @default.
• W2551908528 cites W2065560718 @default.
• W2551908528 cites W2066354143 @default.
• W2551908528 cites W2070648216 @default.
• W2551908528 cites W2070985778 @default.
• W2551908528 cites W2073266640 @default.
• W2551908528 cites W2077994265 @default.
• W2551908528 cites W2087208178 @default.
• W2551908528 cites W2089723533 @default.
• W2551908528 cites W2100683718 @default.
• W2551908528 cites W2111365775 @default.
• W2551908528 cites W2125570430 @default.
• W2551908528 cites W2127825630 @default.
• W2551908528 cites W2130103830 @default.
• W2551908528 cites W2133186034 @default.
• W2551908528 cites W2140211771 @default.
• W2551908528 cites W2141063928 @default.
• W2551908528 cites W2148093987 @default.
• W2551908528 cites W2155024449 @default.
• W2551908528 cites W2155460927 @default.
• W2551908528 cites W2155940374 @default.
• W2551908528 cites W2157373537 @default.
• W2551908528 cites W2162089859 @default.
• W2551908528 cites W2163093841 @default.
• W2551908528 cites W2164109910 @default.
• W2551908528 cites W2165051303 @default.
• W2551908528 cites W2171651020 @default.
• W2551908528 cites W2328786770 @default.
• W2551908528 cites W2405952882 @default.
• W2551908528 cites W4250127314 @default.
• W2551908528 cites W56426715 @default.
• W2551908528 doi "https://doi.org/10.4239/wjd.v7.i19.523" @default.
• W2551908528 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5107712" @default.
• W2551908528 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27895821" @default.
• W2551908528 hasPublicationYear "2016" @default.
• W2551908528 type Work @default.
• W2551908528 sameAs 2551908528 @default.
• W2551908528 citedByCount "8" @default.
• W2551908528 countsByYear W25519085282017 @default.
• W2551908528 countsByYear W25519085282018 @default.
• W2551908528 countsByYear W25519085282020 @default.
• W2551908528 countsByYear W25519085282022 @default.
• W2551908528 crossrefType "journal-article" @default.
• W2551908528 hasAuthorship W2551908528A5001268925 @default.
• W2551908528 hasAuthorship W2551908528A5005742368 @default.
• W2551908528 hasAuthorship W2551908528A5010536397 @default.
• W2551908528 hasAuthorship W2551908528A5075620817 @default.
• W2551908528 hasBestOaLocation W25519085281 @default.
• W2551908528 hasConcept C126322002 @default.
• W2551908528 hasConcept C134018914 @default.
• W2551908528 hasConcept C165220095 @default.
• W2551908528 hasConcept C176685330 @default.
• W2551908528 hasConcept C203014093 @default.
• W2551908528 hasConcept C2779280383 @default.
• W2551908528 hasConcept C2779306644 @default.
• W2551908528 hasConcept C2911091166 @default.
• W2551908528 hasConcept C555293320 @default.
• W2551908528 hasConcept C71924100 @default.
• W2551908528 hasConcept C8891405 @default.
• W2551908528 hasConceptScore W2551908528C126322002 @default.
• W2551908528 hasConceptScore W2551908528C134018914 @default.
• W2551908528 hasConceptScore W2551908528C165220095 @default.
• W2551908528 hasConceptScore W2551908528C176685330 @default.
• W2551908528 hasConceptScore W2551908528C203014093 @default.
• W2551908528 hasConceptScore W2551908528C2779280383 @default.
• W2551908528 hasConceptScore W2551908528C2779306644 @default.
• W2551908528 hasConceptScore W2551908528C2911091166 @default.

• next